Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epoetin alfa vs Placebo in Anemic Cancer Patients on Chemotherapy
NCT00003600Phase 3Completed
- Sponsor
- Cancer and Leukemia Group B
- Start
- Dec 1998
- Primary completion
- Dec 2001
- Modality
- Biologic, rProtein (Recombinant Protein)
- Countries
- 2
01
Overview
A Phase 3 trial of epoetin alfa in anemia, sponsored by Cancer and Leukemia Group B. Started Dec 1998; status: completed.
02
Drugs
epoetin alfa
03
Conditions
anemia
Beyond the preview
Go deeper on NCT00003600.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003600.